The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Valproate in the treatment of epilepsy in girls and women of childbearing potential
Open accessAbstract
Summary: This document provides guidance on the use of valproate in girls and women of childbearing age from a joint Task Force of the Commission on European Affairs of the International League Against Epilepsy (CEA‐ILAE) and the European Academy of Neurology (EAN), following strengthened warnings from the Coordination Group for Mutual Recognition and Decentralised Procedures‐Human (CMD h) of the European Medicines Agency (EMA), which highlight the risk of malformations and developmental problems in infants who are exposed to valproate in the womb. To produce these recommendations, the Task Force has considered teratogenic risks associated with use of valproate and treatment alternatives, the importance of seizure control and of patient and fetal risks with seizures, and the effectiveness of valproate and treatment alternatives in the treatment of different epilepsies. The Task Force's recommendations include the following: (1) Where possible, valproate should be avoided in women of childbearing potential. (2) The choice of treatment for girls and women of childbearing potential should be based on a shared decision between clinician and patient, and where appropriate, the patient's representatives. Discussions should include a careful risk–benefit assessment of reasonable treatment options for the patient's seizure or epilepsy type. (3) For seizure (or epilepsy) types where valproate is the most effective treatment, the risks and benefits of valproate and other treatment alternatives should be discussed. (4) Valproate should not be prescribed as a first‐line treatment for focal epilepsy. (5) Valproate may be offered as a first‐line treatment for epilepsy syndromes where it is the most effective treatment, including idiopathic (genetic) generalized syndromes associated with tonic–clonic seizures. (6) Valproate may be offered as a first‐line treatment in situations where pregnancy is highly unlikely (e.g., significant intellectual or physical disability). (7) Women and girls taking valproate require regular follow‐up for ongoing consideration of the most appropriate treatment regimen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60461-9 · Cited by 969
Self-citationMeador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70323-x · Cited by 834
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Self-citationEthosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
Glauser, T. A., Cnaan, A., Shinnar, S., Hirtz, D. G., Dlugos, D., Masur, D., Clark, P. O., Capparelli, E. V., & Adamson, P. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902014 · Cited by 645
Comparative safety of antiepileptic drugs during pregnancy
Hernández-Díaz, S., Smith, C. R., Shen, A., Mittendorf, R., Hauser, W. A., Yerby, M., Holmes, L. B., For the North American AED Pregnancy Registry, North American AED (Antiepileptic Drug) Pregnancy Registry, Cragan, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f39 · Cited by 620
Chiron, C., Marchand, M., Tran, A., Rey, E., d'Athis, P., Vincent, J., Dulac, O., & Pons, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03157-3 · Cited by 568
Combined analysis of risk factors for SUDEP: Combined SUDEP Analysis
Hesdorffer, D. C., Tomson, T., Benn, E., Sander, J. W., Nilsson, L., Langan, Y., Walczak, T. S., Beghi, E., Brodie, M. J., Hauser, A., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02952.x · Cited by 501
Self-citation(2009) · Neurology · doi:10.1212/wnl.0b013e3181a6b312 · Cited by 428
Samrén, E. B., van Duijn, C. M., Koch, S., Hiilesmaa, V. K., Klepel, H., Bardy, A. H., Mannagetta, G. B., Deichl, A. W., Gaily, E., Granström, I. L., et al. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01480.x · Cited by 406
Self-citationMeador, K., Reynolds, M. W., Crean, S., Fahrbach, K., & Probst, C. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.04.022 · Cited by 400
Congenital malformations due to antiepileptic drugs
Kaneko, S., Battino, D., Andermann, E., Wada, K., Kan, R., Takeda, A., Nakane, Y., Ogawa, Y., Avanzini, G., Fumarola, C., et al. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00084-9 · Cited by 374
Randomised study of antiepileptic drug withdrawal in patients in remission
MEDICALRESEARCHCOUNCILANTIEPILE (1991) · The Lancet · doi:10.1016/0140-6736(91)92856-w · Cited by 354
Nilsson, L., Tomson, T., Farahmand, B. Y., Diwan, V., & Persson, P. G. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01194.x · Cited by 331
Self-citationTopiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register
Hunt, S., Russell, A., Smithson, W. H., Parsons, L., Robertson, I., Waddell, R., Irwin, B., Morrison, P. J., Morrow, J., & Craig, J. (2008) · Neurology · doi:10.1212/01.wnl.0000318293.28278.33 · Cited by 312
Antiepileptic drug use of women with epilepsy and congenital malformations in offspring
Artama, M., Auvinen, A., Raudaskoski, T., Isojärvi, I., & Isojärvi, J. (2005) · Neurology · doi:10.1212/01.wnl.0000163771.96962.1f · Cited by 305
Treatment of pediatric epilepsy: European expert opinion, 2007
Wheless, J. W., Clarke, D. F., Arzimanoglou, A., & Carpenter, D. (2007) · Epileptic Disorders · doi:10.1684/epd.2007.0144 · Cited by 295
Campbell, E., Kennedy, F., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., Hunt, S. J., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306318 · Cited by 292
Sodium Valproate: Monotherapy and Polytherapy
Covanis, A., Gupta, A. K., & Jeavons, P. M. (1982) · Epilepsia · doi:10.1111/j.1528-1157.1982.tb05085.x · Cited by 284
Self-citationTreatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
Bromley, R., Weston, J., Adab, N., Greenhalgh, J., Sanniti, A., McKay, A. J., Tudur Smith, C., & Marson, A. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010236.pub2 · Cited by 277
Self-citationTeratogenic effects of antiepileptic drugs
Tomson, T., & Battino, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70103-5 · Cited by 271
Self-citationIQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study
Baker, G. A., Bromley, R. L., Briggs, M., Cheyne, C. P., Cohen, M. J., García-Fiñana, M., Gummery, A., Kneen, R., Loring, D. W., Mawer, G., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001182 · Cited by 268
Carbamazepine versus valproate monotherapy for epilepsy
Marson, A. G., Williamson, P. R., Hutton, J. L., Clough, H. E., & Chadwick, D. W. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001030 · Cited by 251
Self-citationProgressive myoclonic epilepsies: a review of genetic and therapeutic aspects
Shahwan, A., Farrell, M., & Delanty, N. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70043-0 · Cited by 244
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures
Noachtar, S., Andermann, E., Meyvisch, P., Andermann, F., Gough, W. B., & Schiemann-Delgado, J. (2008) · Neurology · doi:10.1212/01.wnl.0000297512.18364.40 · Cited by 242
Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine
Cummings, C., Stewart, M., Stevenson, M., Morrow, J., & Nelson, J. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2009.176990 · Cited by 205
When antiepileptic drugs aggravate epilepsy
Genton, P. (2000) · Brain and Development · doi:10.1016/s0387-7604(99)00113-8 · Cited by 204
SUDEP and epilepsy‐related mortality in pregnancy
Edey, S., Moran, N., & Nashef, L. (2014) · Epilepsia · doi:10.1111/epi.12621 · Cited by 203
Treatment and Long-Term Prognosis of Myoclonic-Astatic Epilepsy of Early Childhood
Oguni, H., Tanaka, T., Hayashi, K., Funatsuka, M., Sakauchi, M., Shirakawa, S., & Osawa, M. (2002) · Neuropediatrics · doi:10.1055/s-2002-33675 · Cited by 200
Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy
Veiby, G., Daltveit, A. K., Engelsen, B. A., & Gilhus, N. E. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7239-x · Cited by 196
Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years
Cohen, M. J., Meador, K. J., Browning, N., May, R., Baker, G. A., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.08.001 · Cited by 180
Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers
Mawhinney, E., Craig, J., Morrow, J., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0874 · Cited by 165
Nau, H. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90081-x · Cited by 158
The pharmacologic treatment of Dravet syndrome
Chiron, C., & Dulac, O. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03007.x · Cited by 153
Nicolson, A., Appleton, R. E., Chadwick, D. W., & Smith, D. (2004) · PubMed Central · Cited by 144
Tomson, T., Beghi, E., Sundqvist, A., & Johannessen, S. I. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.05.004 · Cited by 143
Self-citationWallace, S. J. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(97)00080-6 · Cited by 137
Long-term prognosis for childhood and juvenile absence epilepsy
Trinka, E., Baumgartner, S., Unterberger, I., Unterrainer, J. M., Luef, G. J., Haberlandt, E., & Bauer, G. J. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0521-1 · Cited by 136
Self-citationBritish Medical Journal Publishing Group (1993) · BMJ · doi:10.1136/bmj.306.6889.1374 · Cited by 136
Liukkonen, E., Kantola‐Sorsa, E., Paetau, R., Gaily, E. K., Peltola, M. E., & Granström, M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02578.x · Cited by 127
Self-citationTrinka, E., Marson, A. G., Van Paesschen, W., Kälviäinen, R., Marovac, J., Duncan, B., Buyle, S., Hallström, Y., Hon, P., Muscas, G. C., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300376 · Cited by 121
Self-citationCause‐specific mortality among patients with epilepsy: Results from a 30‐year cohort study
Trinka, E., Bauer, G. J., Oberaigner, W., Ndayisaba, J., Seppi, K., & Granbichler, C. A. (2012) · Epilepsia · doi:10.1111/epi.12014 · Cited by 109
Self-citationTreatment of Mitochondrial Disorders
Avula, S., Parikh, S., Demarest, S., Kurz, J. E., & Gropman, A. L. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0292-7 · Cited by 108
Possible teratogenicity of valproic acid
Gómez, M. R. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80743-3 · Cited by 100
Multiple treatment comparisons in epilepsy monotherapy trials
Smith, C. T., Marson, A. G., Chadwick, D. W., & Williamson, P. R. (2007) · Trials · doi:10.1186/1745-6215-8-34 · Cited by 97
Self-citationIn utero exposure to levetiracetam vs valproate
Shallcross, R., Bromley, R., Cheyne, C. P., García‐Fiñana, M., Irwin, B., Morrow, J. I., & Baker, G. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000030 · Cited by 93
Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood
Callenbach, P. M. C., Bouma, P. A. D., Geerts, A. T., ARTS, W. F. M., Stroink, H., Peeters, E. A. J., van Donselaar, C. A., Peters, A. C. B., & Brouwer, O. F. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.11.011 · Cited by 92
Cohen, M. J., Meador, K. J., Browning, N., Baker, G. A., Clayton‐Smith, J., Kalayjian, L. A., Kanner, A. M., Liporace, J. D., Pennell, P. B., Privitera, M., et al. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.06.014 · Cited by 87
Fattore, C., Boniver, C., Capovilla, G., Cerminara, C., Citterio, A., Coppola, G., Costa, P., Darra, F., Vecchi, M., & Perucca, E. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02976.x · Cited by 78
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
Posner, E., Mohamed, K., & Marson, A. G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003032.pub2 · Cited by 74
Self-citationNevitt, S. J., Marson, A. G., Pulman, J., & Smith, C. T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001769.pub2 · Cited by 67
Self-citationCause-specific mortality in adult epilepsy patients from Tyrol, Austria: hospital-based study
Granbichler, C. A., Oberaigner, W., Kuchukhidze, G., Bauer, G. J., Ndayisaba, J., Seppi, K., & Trinka, E. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7536-z · Cited by 61
Self-citationAbsence epilepsy: early prognostic signs
Covanis, A., Skiadas, K., Loli, N., Lada, C., & Theodorou, V. (1992) · Seizure · doi:10.1016/1059-1311(92)90038-3 · Cited by 55
Self-citationLevisohn, P. M., & Holland, K. D. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.03.003 · Cited by 54
Non convulsive status epilepticus after replacement of valproate with lamotrigine
Trinka, E., Dilitz, E., Unterberger, I., Luef, G. J., Deisenhammer, F., Niedermüller, U., Thaler, C., & Bauer, G. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0857-3 · Cited by 47
Self-citationTime to 12-month remission and treatment failure for generalised and unclassified epilepsy
Bonnett, L. J., Smith, C. T., Smith, D. F., Williamson, P. R., Chadwick, D. W., & Marson, A. G. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306040 · Cited by 45
Self-citationMyoclonic epilepsy in infancy: An electroclinical study and long‐term follow‐up of 38 patients
Caraballo, R. H., Flesler, S., Pasteris, M. C., Avaria, M. F. L., Fortini, S., & Vilte, C. (2013) · Epilepsia · doi:10.1111/epi.12321 · Cited by 38
Epilepsy with Myoclonic Absences
Genton, P., & Bureau, M. (2006) · CNS Drugs · doi:10.2165/00023210-200620110-00004 · Cited by 29
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
Bromley, R., Pulman, J., Adab, N., Greenhalgh, J., Dickson, R., McKay, A. J., Smith, C. T., & Marson, A. G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010236 · Cited by 23
Self-citationSperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32596-0 · Cited by 2,183
Modulating ROS to overcome multidrug resistance in cancer
Cui, Q., Wang, J.-Q., Assaraf, Y. G., Ren, L., Gupta, P., Wei, L., Ashby, C. R., Yang, D.-H., & Chen, Z.-S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.11.001 · Cited by 661
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Perucca, E., Sabers, A., Thomas, S. V., Vajda, F., Faravelli, F., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30107-8 · Cited by 544
Self-citationHirsch, E., French, J., Scheffer, I. E., Bogacz, A., Alsaadi, T., Sperling, M. R., Abdulla, F., Zuberi, S. M., Trinka, E., Specchio, N., et al. (2022) · Epilepsia · doi:10.1111/epi.17236 · Cited by 502
Self-citationManagement of psychiatric and neurological comorbidities in epilepsy
Kanner, A. M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.243 · Cited by 451
Metadata
- Authors
- Tomson, T., Marson, A., Boon, P., Canevini, M. P., Covanis, A., Gaily, E., Kälviäinen, R., & Trinka, E.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2015-05-16
- Volume
- 56
- Issue
- 7
- Pages
- 1006-1019
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1910200371
- Cited by
- 267
- References
- 61
- FWCI
- 27.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.